Le Lézard
Classified in: Sports and recreation, Covid-19 virus

Women's National Basketball Association (WNBA) Business Analysis Report 2022: Property Profile, Sponsorship and Media Landscape - ResearchAndMarkets.com


The "Business of the Women's National Basketball Association (WNBA) 2022 - Property Profile, Sponsorship and Media Landscape" report has been added to ResearchAndMarkets.com's offering.

The league itself stands to generate $585.5 million from sponsorship deals alone, though this figure is inflated based on a high proportion of deals also being linked to the NBA.

A complete overview of the premier women's basketball competition in the United States. The report takes a closer look at some of the key data surrounding the league, with a particular focus on sponsorship, media and previous league seasons. It is further broken down to analyze the commercial position of its 12 competing teams as well as some of its biggest players.

The WNBA has and continues to be badly affected by the ongoing Russian-Ukraine military crisis thanks to a large number of WNBA players competing in both nations during the WNBA off-season. Teams are growing in commercial and popular appeal and this season will boast four up to four partner logo's on their playing shirts.

Key Highlights

An overview of how the league has performed and been affected by the outbreak of COVID-19 as well as the Russian-Ukraine military crisis. It identifies the commercial position of all involved parties as well as the trends that have started to emerge across women's basketball over the past few seasons. It also offers key insight into the finances associated with the league via sponsorship and media revenue streams.

Scope

Reasons to Buy

Key Topics Covered:

2021 Attendances Table

2021 Ticket Revenue Table

List of Figures

For more information about this report visit https://www.researchandmarkets.com/r/934rd0


These press releases may also interest you

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
Discovery Silver Corp. ("Discovery" or the "Company") today announced financial results for the three and twelve months ended December 31, 2023 ("Q4 2023" and "2023", respectively). The Company also provided a summary of key events since the...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

28 mar 2024
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...



News published on and distributed by: